Apyx Medical Corporation (APYX)
USD 1.16
(-5.69%)
USD 1.16
(-5.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -18.11 Million USD | 15.88% |
| 2022 | -22 Million USD | -54.6% |
| 2021 | -13.9 Million USD | 23.51% |
| 2020 | -18.47 Million USD | 2.71% |
| 2019 | -19.07 Million USD | -52.37% |
| 2018 | -13.91 Million USD | -249.16% |
| 2017 | -13 Million USD | 1.34% |
| 2016 | -3.79 Million USD | 45.72% |
| 2015 | -4.37 Million USD | -19.44% |
| 2014 | -12.25 Million USD | -143.1% |
| 2013 | -3.68 Million USD | -226.43% |
| 2012 | 1.93 Million USD | 107.07% |
| 2011 | 1.19 Million USD | 193.61% |
| 2010 | -1.23 Million USD | -82.5% |
| 2009 | 1.78 Million USD | 132.71% |
| 2008 | 3.8 Million USD | -73.28% |
| 2007 | 2.87 Million USD | -8.75% |
| 2006 | 3.15 Million USD | 231.96% |
| 2005 | 949.84 Thousand USD | -43.25% |
| 2004 | 1.67 Million USD | 50.92% |
| 2003 | 978.14 Thousand USD | 1541.21% |
| 2002 | -199.01 Thousand USD | -107.28% |
| 2001 | 1.15 Million USD | 15.23% |
| 2000 | 926.7 Thousand USD | 150.16% |
| 1999 | 947.2 Thousand USD | -1081.7% |
| 1998 | -133.07 Thousand USD | -125.12% |
| 1997 | 650.71 Thousand USD | -15.56% |
| 1996 | 741 Thousand USD | 789.98% |
| 1995 | -48.5 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -5.39 Million USD | 17.23% |
| 2024 Q1 | -6.61 Million USD | 27.63% |
| 2023 FY | - USD | 15.88% |
| 2023 Q1 | -5.56 Million USD | 5.85% |
| 2023 Q4 | -5.62 Million USD | -21.29% |
| 2023 Q3 | -4.63 Million USD | -49.48% |
| 2023 Q2 | -3.1 Million USD | 44.26% |
| 2022 Q3 | -5.52 Million USD | -8.31% |
| 2022 FY | - USD | -54.6% |
| 2022 Q4 | -5.91 Million USD | -6.93% |
| 2022 Q2 | -5.1 Million USD | 9.9% |
| 2022 Q1 | -5.66 Million USD | -202.13% |
| 2021 Q4 | -1.87 Million USD | 52.22% |
| 2021 FY | - USD | 23.51% |
| 2021 Q1 | -4.83 Million USD | -152.48% |
| 2021 Q2 | -3.72 Million USD | 22.87% |
| 2021 Q3 | -3.92 Million USD | -5.23% |
| 2020 FY | - USD | 2.71% |
| 2020 Q3 | -4.42 Million USD | 25.63% |
| 2020 Q2 | -5.94 Million USD | 10.35% |
| 2020 Q1 | -6.63 Million USD | -14.26% |
| 2020 Q4 | -1.91 Million USD | 56.71% |
| 2019 Q1 | -4.61 Million USD | -3.43% |
| 2019 FY | - USD | -52.37% |
| 2019 Q4 | -5.8 Million USD | -40.29% |
| 2019 Q3 | -4.14 Million USD | 0.0% |
| 2019 Q2 | -4.14 Million USD | 10.21% |
| 2018 Q1 | -864 Thousand USD | -298.17% |
| 2018 Q3 | -2.89 Million USD | -2945.26% |
| 2018 Q4 | -4.45 Million USD | -54.1% |
| 2018 FY | - USD | -249.16% |
| 2018 Q2 | -95 Thousand USD | 89.0% |
| 2017 Q3 | -963 Thousand USD | 14.63% |
| 2017 FY | - USD | 1.34% |
| 2017 Q2 | -1.12 Million USD | 27.65% |
| 2017 Q1 | -1.55 Million USD | -49.33% |
| 2017 Q4 | 436 Thousand USD | 145.28% |
| 2016 Q4 | -1.04 Million USD | -2272.73% |
| 2016 Q3 | -44 Thousand USD | 91.37% |
| 2016 Q2 | -510 Thousand USD | 71.84% |
| 2016 Q1 | -1.81 Million USD | -33.75% |
| 2016 FY | - USD | 45.72% |
| 2015 FY | - USD | -19.44% |
| 2015 Q4 | -1.35 Million USD | 15.53% |
| 2015 Q3 | -1.6 Million USD | -19.27% |
| 2015 Q2 | -1.34 Million USD | 34.6% |
| 2015 Q1 | -2.05 Million USD | -14.68% |
| 2014 Q2 | -1.52 Million USD | -625.86% |
| 2014 Q1 | 290 Thousand USD | 122.71% |
| 2014 Q3 | -2.16 Million USD | -41.9% |
| 2014 FY | - USD | -143.1% |
| 2014 Q4 | -1.79 Million USD | 17.19% |
| 2013 Q3 | -271 Thousand USD | 33.09% |
| 2013 FY | - USD | -226.43% |
| 2013 Q4 | -1.27 Million USD | -371.22% |
| 2013 Q2 | -405 Thousand USD | 10.6% |
| 2013 Q1 | -453 Thousand USD | -231.3% |
| 2012 Q2 | 456 Thousand USD | -26.45% |
| 2012 Q3 | 482 Thousand USD | 5.7% |
| 2012 FY | - USD | 107.07% |
| 2012 Q4 | 345 Thousand USD | -28.42% |
| 2012 Q1 | 620 Thousand USD | 154.34% |
| 2011 Q4 | -1.14 Million USD | -341.74% |
| 2011 Q3 | 472 Thousand USD | -29.13% |
| 2011 Q1 | 870 Thousand USD | -43.92% |
| 2011 Q2 | 666 Thousand USD | -23.45% |
| 2011 FY | - USD | 193.61% |
| 2010 FY | - USD | -82.5% |
| 2010 Q3 | -36.28 Thousand USD | 96.82% |
| 2010 Q4 | 1.55 Million USD | 4375.84% |
| 2010 Q2 | -1.14 Million USD | -1798.84% |
| 2010 Q1 | -60.14 Thousand USD | -118.92% |
| 2009 Q1 | 774.07 Thousand USD | 91.06% |
| 2009 Q4 | 317.9 Thousand USD | 87.55% |
| 2009 Q3 | 169.5 Thousand USD | -68.1% |
| 2009 Q2 | 531.41 Thousand USD | -31.35% |
| 2009 FY | - USD | 132.71% |
| 2008 Q4 | 405.13 Thousand USD | -52.24% |
| 2008 Q2 | -1.02 Million USD | -290.67% |
| 2008 Q1 | 535.61 Thousand USD | -14.96% |
| 2008 FY | - USD | -73.28% |
| 2008 Q3 | 848.3 Thousand USD | 183.07% |
| 2007 Q1 | 183.33 Thousand USD | -65.56% |
| 2007 Q2 | 114.82 Thousand USD | -37.37% |
| 2007 Q4 | 629.83 Thousand USD | -31.8% |
| 2007 Q3 | 923.53 Thousand USD | 704.32% |
| 2007 FY | - USD | -8.75% |
| 2006 Q2 | 602.87 Thousand USD | 5.04% |
| 2006 Q3 | 701.24 Thousand USD | 16.32% |
| 2006 Q4 | 532.32 Thousand USD | -24.09% |
| 2006 FY | - USD | 231.96% |
| 2006 Q1 | 573.91 Thousand USD | 21.45% |
| 2005 FY | - USD | -43.25% |
| 2005 Q3 | 258.73 Thousand USD | 1201.04% |
| 2005 Q4 | 472.54 Thousand USD | 82.63% |
| 2005 Q1 | 191.17 Thousand USD | -4.4% |
| 2005 Q2 | 19.88 Thousand USD | -89.6% |
| 2004 FY | - USD | 50.92% |
| 2004 Q1 | 331.99 Thousand USD | 312.88% |
| 2004 Q2 | 512.78 Thousand USD | 54.46% |
| 2004 Q3 | 628.91 Thousand USD | 22.65% |
| 2004 Q4 | 199.97 Thousand USD | -68.2% |
| 2003 FY | - USD | 1541.21% |
| 2003 Q2 | 589.96 Thousand USD | 306.51% |
| 2003 Q1 | 145.12 Thousand USD | 155.17% |
| 2003 Q4 | -155.95 Thousand USD | -134.82% |
| 2003 Q3 | 447.93 Thousand USD | -24.07% |
| 2002 Q2 | 14.49 Thousand USD | -47.8% |
| 2002 FY | - USD | -107.28% |
| 2002 Q4 | -263.07 Thousand USD | -1306.64% |
| 2002 Q3 | 21.8 Thousand USD | 50.46% |
| 2002 Q1 | 27.76 Thousand USD | -79.76% |
| 2001 Q2 | 364.61 Thousand USD | 117.55% |
| 2001 Q4 | 137.15 Thousand USD | -67.72% |
| 2001 Q3 | 424.91 Thousand USD | 29.27% |
| 2001 Q1 | 180.64 Thousand USD | -27.81% |
| 2001 FY | - USD | 15.23% |
| 2000 Q1 | 122.98 Thousand USD | 0.0% |
| 2000 Q2 | 356.75 Thousand USD | 250.77% |
| 2000 Q3 | 244.63 Thousand USD | -29.23% |
| 2000 FY | - USD | 150.16% |
| 2000 Q4 | 202.33 Thousand USD | -14.42% |
| 1999 FY | - USD | -1081.7% |
| 1998 FY | - USD | -125.12% |
| 1997 FY | - USD | -15.56% |
| 1996 FY | - USD | 789.98% |
| 1995 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -34.292% |
| Cerus Corporation | -26.53 Million USD | 31.746% |
| OrthoPediatrics Corp. | -8.38 Million USD | -116.108% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -72.586% |
| Talis Biomedical Corporation | -66.04 Million USD | 72.576% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -8.618% |
| Inogen, Inc. | -45.67 Million USD | 60.349% |
| Spectral AI, Inc. | -12.26 Million USD | -47.708% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 62.024% |
| CVRx, Inc. | -38.73 Million USD | 53.236% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -413.379% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -49.599% |
| Orthofix Medical Inc. | -86.98 Million USD | 79.178% |
| Venus Concept Inc. | -26.11 Million USD | 30.64% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 63.609% |
| Bioventus Inc. | -23.07 Million USD | 21.491% |
| BrainsWay Ltd. | -2.31 Million USD | -683.73% |
| Envoy Medical, Inc. | -18.23 Million USD | 0.691% |
| electroCore, Inc. | -17.76 Million USD | -1.982% |
| IceCure Medical Ltd | -15.25 Million USD | -18.744% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 63.595% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -7.453% |
| MaxCyte, Inc. | -44.12 Million USD | 58.956% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -54.066% |
| Nexalin Technology, Inc. | -5.69 Million USD | -218.199% |
| PAVmed Inc | -75.74 Million USD | 76.087% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 66.308% |
| RxSight, Inc. | -41.03 Million USD | 55.864% |
| Sight Sciences, Inc. | -49.41 Million USD | 63.347% |
| SI-BONE, Inc. | -34.44 Million USD | 47.419% |
| TELA Bio, Inc. | -40.63 Million USD | 55.425% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 68.932% |
| Treace Medical Concepts, Inc. | -39 Million USD | 53.568% |
| LivaNova PLC | 39.01 Million USD | 146.422% |
| 908 Devices Inc. | -34.02 Million USD | 46.769% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 83.623% |
| Nemaura Medical Inc. | -7.28 Million USD | -148.55% |
| NeuroPace, Inc. | -22.83 Million USD | 20.68% |
| LENSAR, Inc. | -8.71 Million USD | -107.849% |
| Cutera, Inc. | -136.56 Million USD | 86.737% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -435.858% |
| BioSig Technologies, Inc. | -28.15 Million USD | 35.661% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 819.873% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 13.707% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 104.722% |
| Axonics, Inc. | 7.77 Million USD | 332.952% |
| Outset Medical, Inc. | -153.78 Million USD | 88.223% |
| IRIDEX Corporation | -7.44 Million USD | -143.179% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 81.536% |
| IRadimed Corporation | 20.8 Million USD | 187.074% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -124.659% |
| INVO Bioscience, Inc. | -6.88 Million USD | -163.255% |
| Telesis Bio, Inc. | -40.49 Million USD | 55.271% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 149.382% |
| Varex Imaging Corporation | 67.2 Million USD | 126.952% |
| Quipt Home Medical Corp. | 44.07 Million USD | 141.097% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -66.624% |
| Pulmonx Corporation | -55.09 Million USD | 67.124% |
| Dynatronics Corporation | -976 Thousand USD | -1755.722% |
| Modular Medical, Inc. | -17.1 Million USD | -5.9% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -25.04% |
| Semler Scientific, Inc. | 23.58 Million USD | 176.782% |
| InMode Ltd. | 196.28 Million USD | 109.227% |
| Bruker Corporation | 599 Million USD | 103.024% |
| Cytosorbents Corporation | -28.81 Million USD | 37.135% |
| DexCom, Inc. | 916.7 Million USD | 101.976% |
| Align Technology, Inc. | 799.03 Million USD | 102.267% |
| Viveve Medical, Inc. | -20.61 Million USD | 12.15% |
| ZimVie Inc. | 91.07 Million USD | 119.887% |
| Movano Inc. | -29.12 Million USD | 37.813% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -310.889% |
| Nexalin Technology, Inc. | -5.69 Million USD | -218.199% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -413.379% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 90.695% |
| Profound Medical Corp. | -27.12 Million USD | 33.224% |
| Insulet Corporation | 323.6 Million USD | 105.597% |
| enVVeno Medical Corporation | -25.01 Million USD | 27.604% |
| Surmodics, Inc. | 1.18 Million USD | 1624.579% |
| iCAD, Inc. | -6.56 Million USD | -175.887% |
| Nuwellis, Inc. | -16.35 Million USD | -10.736% |
| Biotricity, Inc. | -8.82 Million USD | -105.159% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 81.301% |
| Aethlon Medical, Inc. | -11.84 Million USD | -52.855% |
| InspireMD, Inc. | -20.91 Million USD | 13.385% |
| PAVmed Inc. | -75.74 Million USD | 76.087% |
| BIOLASE, Inc. | -15.13 Million USD | -19.638% |
| Beyond Air, Inc. | -59.03 Million USD | 69.318% |
| FONAR Corporation | 28.25 Million USD | 164.11% |
| AxoGen, Inc. | -13.32 Million USD | -35.894% |
| Vivani Medical, Inc. | -26.6 Million USD | 31.93% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 173.803% |
| Inari Medical, Inc. | 7.11 Million USD | 354.632% |
| UFP Technologies, Inc. | 72.74 Million USD | 124.899% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -434.942% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -194.217% |
| Tenon Medical, Inc. | -15.52 Million USD | -16.641% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -18.643% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 56.331% |
| AdaptHealth Corp. | -171.09 Million USD | 89.414% |
| Sintx Technologies, Inc. | -6.6 Million USD | -174.424% |
| NanoVibronix, Inc. | -3.43 Million USD | -427.278% |
| Quanterix Corporation | -38.08 Million USD | 52.447% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -66.624% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 60473.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 93.468% |
| TransMedics Group, Inc. | -7.6 Million USD | -138.222% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 16.784% |
| NeuroMetrix, Inc. | -7.09 Million USD | -155.249% |
| Hyperfine, Inc. | -47.06 Million USD | 61.514% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 68.937% |
| Biomerica, Inc. | -5.99 Million USD | -202.219% |
| Bone Biologics Corporation | 479.57 Thousand USD | 3876.701% |
| AVITA Medical, Inc. | -39.56 Million USD | 54.225% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -97.45% |
| Silk Road Medical, Inc | -45.08 Million USD | 59.823% |